Swiss Lions 100 | 2026 edition

Siegfried

Siegfried is No. 71 in the Swiss Lions 100 and No. 6 in Pharma & Biotech, with a score of 44.1 out of 100. Headquarters: Zofingen, canton of Aargau.

Top Pharma & Biotech The full ranking
Swiss Lions score
44.1
Overall rank
71of 100

About

Contract developer and manufacturer of active ingredients and finished medicines, headquartered in Zofingen, canton of Aargau.

How the score is made

Global scale

36.9

CHF 1.3bn revenue.

Swiss value

60

Partly Swiss made.

Global visibility

25.4

Online attention across languages, and worldwide search interest.

Impact

50

Net-zero target validated. Not a certified B Corp.

Philanthropy

0

No charitable foundation found.

Impact and philanthropy together make up the impact measure. How the ranking works.

Key figures

Revenue used in the ranking
CHF 1.3bn12 months to June 2026, company
Revenue
CHF 1.3bnTwelve months to 30 June 2026
Net profit
CHF 171mAttributable to shareholders
Dividends paid
CHF 18mTo all shareholders
Employees worldwide
4,454

Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.

Profile

Headquarters
ZofingenCanton of Aargau
Language region
German-speaking
Ownership
Listed
Main customers
Businesses (B2B)
Chief executive
Marcel ImwinkelriedSource
Founded
1873

Nearby in the Swiss Lions 100

Also in Pharma & Biotech

See all 8 brands in Pharma & Biotech.

Sources

  • Revenue used in the ranking: stockanalysis.com SFZN (12 months to June 2026).
  • Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
  • Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.

Something out of date?

If a figure is wrong, or Siegfried can publish figures for the next edition, tell us. Corrections are recorded with their source.

Send a correction How the ranking works
Scroll to Top